This website uses cookies
Read our Privacy policy and Terms of use for more information.
Global Supply
Mar 26, 2026
•
14 min read
FDA's staffing crisis has been well documented for drug developers. For the independent operators now carrying plasma's collection growth, the exposure is more specific, less visible, and not yet in any model.
Mar 17, 2026
The Egypt Unlock: Grifols just proved that a compensated, non-Western plasma platform can clear the EMA bar.
